Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications From Clinical Features to Pathologic Findings.

Zhou, Xin; Li, Yongle; Yang, Qing

Zhou, Xin; Li, Yongle; Yang, Qing.

Zhou X; Department of Cardiology, Tianjin Medical University General Hospital, China.
Li Y; Department of Cardiology, Tianjin Medical University General Hospital, China.
Yang Q; Department of Cardiology, Tianjin Medical University General Hospital, China.

Circulation ; 141(22): 1736-1738, 2020 06 02.

Article in English | MEDLINE | ID: covidwho-962886

Subject(s)

Acute Coronary Syndrome/drug therapy; Coronavirus Infections/pathology; Platelet Aggregation Inhibitors/therapeutic use; Pneumonia, Viral/pathology; Acute Coronary Syndrome/complications; Acute Coronary Syndrome/pathology; Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/complications; Coronavirus Infections/virology; Disease Progression; Hemorrhage/etiology; Humans; Lung/pathology; Pandemics; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors/adverse effects; Platelet Count; Pneumonia, Viral/complications; Pneumonia, Viral/virology; SARS-CoV-2

Keywords

COVID-19; coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Platelet Aggregation Inhibitors / Coronavirus Infections / Acute Coronary Syndrome Type of study: Experimental Studies / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Circulation Year: 2020 Document Type: Article Affiliation country: CIRCULATIONAHA.120.046988

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google